Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v4-FR
Language English French
Date Updated 2023-02-09 2021-03-24
Drug Identification Number 01934333 01934333
Brand name DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML
Common or Proper name DEPO-MEDROL DEPO-MEDROL
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METHYLPREDNISOLONE ACETATE METHYLPREDNISOLONE ACETATE
Strength(s) 40MG 40MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL
Packaging size 5 x 2mL 5 x 2mL
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-09-13
Actual start date 2021-09-08
Estimated end date 2023-02-09 2022-04-01
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Other presentations remain available.
Health Canada comments